Touyun Biotech Group Limited (HKG:1332)

Touyun Biotech Group Statistics

Total Valuation

HKG:1332 has a market cap or net worth of HKD 356.36 million. The enterprise value is 902.71 million.

Market Cap	356.36M
Enterprise Value	902.71M

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1332 has 2.81 billion shares outstanding.

Current Share Class	2.81B
Shares Outstanding	2.81B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	39.62%
Owned by Institutions (%)	0.01%
Float	1.69B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.48
PB Ratio	-57.78
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-31.24
EV / Sales	6.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-18.35

Financial Position

The company has a current ratio of 0.20

Current Ratio	0.20
Quick Ratio	0.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-10.17
Interest Coverage	-5.51

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-5.94%
Return on Invested Capital (ROIC)	-11.67%
Return on Capital Employed (ROCE)	4,006.19%
Weighted Average Cost of Capital (WACC)	1.75%
Revenue Per Employee	308,837
Profits Per Employee	-62,140
Employee Count	465
Asset Turnover	0.24
Inventory Turnover	5.04

Taxes

In the past 12 months, HKG:1332 has paid 11,000 in taxes.

Income Tax	11,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.49% in the last 52 weeks. The beta is -0.42, so HKG:1332's price volatility has been lower than the market average.

Beta (5Y)	-0.42
52-Week Price Change	-23.49%
50-Day Moving Average	0.20
200-Day Moving Average	0.15
Relative Strength Index (RSI)	44.66
Average Volume (20 Days)	42,684,025

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1332 had revenue of HKD 143.61 million and -28.90 million in losses. Loss per share was -0.01.

Revenue	143.61M
Gross Profit	61.57M
Operating Income	-56.29M
Pretax Income	-15.52M
Net Income	-28.90M
EBITDA	-43.03M
EBIT	-56.29M
Loss Per Share	-0.01

Balance Sheet

The company has 11.53 million in cash and 500.21 million in debt, with a net cash position of -488.68 million or -0.17 per share.

Cash & Cash Equivalents	11.53M
Total Debt	500.21M
Net Cash	-488.68M
Net Cash Per Share	-0.17
Equity (Book Value)	-6.17M
Book Value Per Share	-0.02
Working Capital	-492.67M

Cash Flow

In the last 12 months, operating cash flow was -46.83 million and capital expenditures -2.37 million, giving a free cash flow of -49.19 million.

Operating Cash Flow	-46.83M
Capital Expenditures	-2.37M
Free Cash Flow	-49.19M
FCF Per Share	-0.02

Margins

Gross margin is 42.87%, with operating and profit margins of -39.19% and -20.12%.

Gross Margin	42.87%
Operating Margin	-39.19%
Pretax Margin	-10.81%
Profit Margin	-20.12%
EBITDA Margin	-29.97%
EBIT Margin	-39.19%
FCF Margin	n/a

Dividends & Yields

HKG:1332 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-8.11%
FCF Yield	-13.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 12, 2019. It was a reverse split with a ratio of 0.25.

Last Split Date	Aug 12, 2019
Split Type	Reverse
Split Ratio	0.25

Scores

HKG:1332 has an Altman Z-Score of -5.43 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.43
Piotroski F-Score	1